Status
Conditions
Treatments
About
Urolithiasis is a common urological disease with an increasing prevalence and high recurrence rates, negatively affecting patients' quality of life. Extracorporeal shock wave lithotripsy is a frequently preferred non-invasive treatment option in appropriate cases; however, uncertainties related to the procedural process and inadequate patient information may lead to increased anxiety and a decline in quality of life. Structured patient education delivered under nurse leadership has emerged as a potential approach to mitigate these adverse effects. Nevertheless, studies evaluating the impact of structured patient education on anxiety levels and quality of life in patients undergoing extracorporeal shock wave lithotripsy remain limited.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Aged between 18 and 65 years, Diagnosed with urolithiasis, Scheduled for elective extracorporeal shock wave lithotripsy (ESWL), Undergoing ESWL for the first time.
Exclusion criteria
Previous history of ESWL treatment, Urolithiasis cases requiring urgent intervention, Presence of renal insufficiency, active urinary tract infection, coagulopathy, or severe cardiopulmonary comorbidities, Inability to discontinue anticoagulant or antiplatelet therapy, Pregnancy.
Primary purpose
Allocation
Interventional model
Masking
188 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal